EPILEPSY AND BEHAVIORSchmidt D. Drug treatment of epilepsy: Options and limitations. Epilepsy Behav 2009;15:56-65.Drug treatment of epilepsy: Options and limitations[J] . Dieter Schmidt.Epilepsy and Behavior . 2009 (1)Schmidt D (2009) Drug treatment of epilepsy: options and limitations. ...
In this Review, we assess recent progress in ASM development and outline future directions for the development of new therapies for the treatment and prevention of epilepsy. This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature ...
M. et al. Myoclonic epilepsy and ragged-red fiber disease (MERRF) is associated with a mitochondrial DNA tRNA(Lys) mutation. Cell 61, 931–937 (1990). Article CAS PubMed Google Scholar Zeviani, M. et al. A MERRF/MELAS overlap syndrome associated with a new point mutation in the ...
The study authors believe that the modification of teriflunomide and the development of new DHODH inhibitors is urgent for drug-resistant epilepsy patients A drug commonly used to treat multiple sclerosis may one day be used to treat patients with Dravet Syndrome, a rare form of epilepsy, ...
Antiepileptic drug randomized controlled trial (RCT) design has been criticized for its emphasis on regulatory, licensing aspects rather than clinical considerations. A new study that scrutinized RCT patient recruitment has also raised important ethical issues. At a time when RCT patient recruitment in ...
Neurostimulation in the treatment of epilepsy There is increased interest in neurostimulation as a treatment for drug-resistant epilepsy. Two large pivotal trials have recently been completed, one usin... Bergey,K Gregory - 《Experimental Neurology》 被引量: 79发表: 2013年 Neurostimulation therapy for...
The medical condition, Cerebral Cavernous Malformations (CCM), occurs when abnormal and dilated thin-walled blood vessels form clusters in the brain, altering blood flow, according to the institute. CCM affects as many as one in 200 people and can cause bleeding, epilepsy and stroke. ...
It’s important for individuals with epilepsy to consult healthcare professionals about their treatment options. With the continued efforts of epilepsy drug companies and advancements in research, the future looks promising for those living with this condition. Knowledge, support, and effective medication...
SUMMARY: Careful attention needs to be given to the identification and confirmation of the practical importance of mechanisms postulated to underlie drug resistance in human epilepsy. If certain mechanisms are shown to be involved, then new therapeutic options for drug-resistant human epilepsy may be ...
Epilepsy is a common and debilitating brain disorder for which current antiseizure medications (ASMs) provide inadequate efficacy in around 30% of patients. In their Review, Pavel Klein and colleagues survey the diverse ASM pipeline, including new approaches to target specific epilepsy syndromes, and...